Skip to main content
Cancer Biomarkers: Section A of Disease Markers logoLink to Cancer Biomarkers: Section A of Disease Markers
. 2013 Oct 31;13(4):281–288. doi: 10.3233/CBM-130351

Genomic changes in rectal adenocarcinoma associated with liver metastasis

Hai-Tao Zhou a,1, Zhi-Zhou Shi b,1, Zhi-Xiang Zhou a, Yan-Yi Jiang b, Jia-Jie Hao b, Tong-Tong Zhang b, Feng Shi b, Xin Xu b, Ming-Rong Wang b, Yu Zhang b,*
PMCID: PMC12928293  PMID: 24240589

Abstract

Background:

At present no objective parameters to identify the risk of liver metastasis after surgery have been established in rectal cancer.

Objective:

To identify the chromosomal aberrations that are correlated with liver metastasis of rectal cancer.

Methods:

Primary tumor tissues of rectal carcinoma were analyzed by array-based comparative genomic hybridization (array-CGH). Genomic aberrations were identified by Genomic Workbench and MD-SeeGH.

Results:

The most frequent gains in rectal cancer were at 20q11.21-q13.33, 8q11.21-q24.3, 13q12.11-q14.2 and losses in 5q13.2, 8p23.3-p22, 17p13.3-p13.2 and 18q11.2-q23. Seven amplifications at 6p21.1, 8q24.21, 8q24.3, 13q13.2 and 20q13.2-q13.32 and nine homozygous deletions at 1q31.3, 4q12-q13.1, 4q32.3-q33, 5q13.2, 8p23.2, 8q11.23, 16p13.2, 19p13.11 and 19q13.41 were identified. Both frequency plot comparison and SAM (Significance analysis of microarray) methods indicated that losses at 1p35.3, 4p14, 14q23.1-q32.11 and 18p11.32-p11.21 were more frequent in patients without liver metastasis.

Conclusions:

These liver metastasis associated genomic changes may be useful to reveal the mechanism of metastasis and identify candidate biomarkers.

Keywords: Array CGH, rectal cancer, liver metastasis, biomarker

Full Text

The Full Text of this article is available as a PDF (656.4 KB).


Articles from Cancer Biomarkers: Section A of Disease Markers are provided here courtesy of SAGE Publications

RESOURCES